A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
1999/12/01 · 48 citations
Medicine · Neuroscience · Psychology · #Attention Deficit Hyperactivity Disorder #Neurotransmitter Receptor Influence on Behavior #Behavioral and Psychological Studies
paper · doi:10.1001/archpsyc.56.12.1073
Abstract
BACKGROUND: Previous studies have demonstrated the short-term efficacy of pharmacotherapy and behavior therapy for attention-deficit/hyperactivity disorder (ADHD), but no longer-term (i.e., >4 months) investigations have compared these 2 treatments or their combination. METHODS: A group of 579 children with ADHD Combined Type, aged 7 to 9.9 years, were assigned to 14 months of medication management (titration followed by monthly visits); intensive behavioral treatment (parent, school, and child components, with therapist involvement gradually reduced over time); the two combined; or standard community care (treatments by community providers). Outcomes were assessed in multiple domains before and during treatment and at treatment end point (with the combined treatment and medication management groups continuing medication at all assessment points). Data were analyzed through intent-to-treat random-effects regression procedures. RESULTS: All 4 groups showed sizable reductions in symptoms over time, with significant differences among them in degrees of change. For most ADHD symptoms, children in the combined treatment and medication management groups showed significantly greater improvement than those given intensive behavioral treatment and community care. Combined and medication management treatments did not differ significantly on any direct comparisons, but in several instances (oppositional/aggressive symptoms, internalizing symptoms, teacher-rated social skills, parent-child relations, and reading achievement) combined treatment proved superior to intensive behavioral treatment and/or community care while medication management did not. Study medication strategies were superior to community care treatments, despite the fact that two thirds of community-treated subjects received medication during the study period. CONCLUSIONS: For ADHD symptoms, our carefully crafted medication management was superior to behavioral treatment and to routine community care that included medication. Our combined treatment did not yield significantly greater benefits than medication management for core ADHD symptoms, but may have provided modest advantages for non-ADHD symptom and positive functioning outcomes.
Cited by
- Acceptability of Behavioral and Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder: Relations to Child and Parent Characteristics
- Attention-Deficit/Hyperactivity Disorder in a Diverse Culture: Do Research and Clinical Findings Support the Notion of a Cultural Construct for the Disorder?
- Practitioner Review: It's time to bridge the gap – understanding the unmet needs of consumers with attention‐deficit/hyperactivity disorder – a systematic review and recommendations
- School readiness and later achievement.
- How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition
- Stimulant ADHD medication and risk for substance abuse
- Attention deficit hyperactivity disorder in children: moving forward with divergent perspectives
- In the long run, skills are as good as pills for attention deficit hyperactivity disorder
- Mother–Child Relationships of Children with ADHD: The Role of Maternal Depressive Symptoms and Depression-Related Distortions
- Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA
- Neurodevelopmental disorders
- Might stimulant drugs support moral agency in ADHD children?
- ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults
- Psychotherapy of attention deficit hyperactivity disorder in adults
- Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations.
- Attention Problems and Executive Functions in Children With Spina Bifida and Hydrocephalus
- Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression
- Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology
- Systematic review of national and international guidelines on attention-deficit hyperactivity disorder
- Parent Involvement in Treatment for ADHD: A Meta-Analysis of the Published Studies
- Attention-Deficit Hyperactivity Disorder and Problems in Peer Relations: Predictions From Childhood to Adolescence
- Empirical Investigation of Twice-Exceptionality: Where Have We Been and Where Are We Going?
- How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. [europepmc]
- The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. [europepmc]
- State of the science on psychosocial interventions for ethnic minorities. [europepmc]
- Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale - parent form. [europepmc]
- Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. [europepmc]
- Evidence-based psychosocial treatments for ethnic minority youth. [europepmc]
- The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. [europepmc]
- Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. [europepmc]
- ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. [europepmc]
- Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. [europepmc]
- Prospective follow-up of girls with attention-deficit/hyperactivity disorder into early adulthood: continuing impairment includes elevated risk for suicide attempts and self-injury. [europepmc]
- A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. [europepmc]
- Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. [europepmc]
- Medication for attention deficit-hyperactivity disorder and criminality. [europepmc]
- Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. [europepmc]
- Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. [europepmc]
- Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. [europepmc]
- The Status of Irritability in Psychiatry: A Conceptual and Quantitative Review. [europepmc]
- Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. [europepmc]
- The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. [europepmc]
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. [europepmc]
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. [europepmc]
- Attention-deficit hyperactivity disorder. [europepmc]
- ADHD: Current Concepts and Treatments in Children and Adolescents. [europepmc]
- Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. [europepmc]
Related